Session Details

[P1]A

Mon. Nov 10, 2025 4:15 PM - 4:45 PM JST
Mon. Nov 10, 2025 7:15 AM - 7:45 AM UTC
P1(4F)

[P1-001-A]A case study of improvement of mortality of pre-weaning unit and fattening unit by administration of PRRSV1 live vaccine at a pig farm in Nagasaki, Japan

*Takao Mishima1, Daisuke Inoue2 (1. Guardian Nagasaki Co., Ltd. (Japan), 2. Kennan Livestock Hygiene Service Center, Nagasaki Prefecture (Japan))

[P1-004-A]Efficacy of UNISTRAIN® PRRS Vaccination in Piglets for Controlling PRRSV1 and PRRSV2 Coinfection in a Korean Swine Farm

*JeongJae Byun1, Hyundong Noh1, Sungwoon Choi1, Sanghyun Noh1, Salvador Romero2, Junghee Kim3 (1. HIPRA KOREA (Korea), 2. HIPRA HQ (Spain), 3. UNI Animal Hospital (Korea))

[P1-007-A]EVALUATION OF A PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE AGAINST A NADC34-LIKE VIRUS STRAIN IN A TAIWANESE FARM

*Chun-Wei (David) Liu1, Chao-Wen (Valen) Hsueh1, Cheng-Han Yang1 (1. Zoetis Taiwan limited (Taiwan))

[P1-010-A]Efficacy of a type 2 PRRS MLV against type 1 and type 2 PRRS dual naturally exposed swine farm

*Yusik Oh1, JongYeon Jeong1, Minsoo Choi2 (1. Boehringer Ingelheim Animal Health Korea (Korea), 2. Gwanghee animal hospital (Korea))

[P1-016-A]Relationship between Porcine Reproductive and Respiratory Syndrome Virus antigen CT values in weaned piglets and subsequent production performance

*Xin Zhang1, Min Cui1, Liwei Zhao1, Lei Yang1, Chengxin Wei1, Yunlong Wang1 (1. Yantai Longda Breeding Co.,Ltd (China))

[P1-019-A]PHYLOGENETIC ANALYSIS OF ORF5 OF PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS IN CENTRAL-SOUTHERN REGION OF TAIWAN IN 2023-2025

Hung Chih Kuo1, *Chia Yu Hsu1, Teng Yuan Lo1, Ching Fen Wu1 (1. Department of Veterinary Medicine, National Chiayi University (Taiwan))

[P1-022-A]Association between genotype and virulence of porcine reproductive and respiratory syndrome virus strains prevalent in Japan

*Yuka Eto1, Fumiko Koike1, Satoshi Murata1, Fumie Shimokawa2, Masaru Murakami2 (1. SMC Co.,Ltd (Japan), 2. Azabu University School of Veterinary Medicine (Japan))

[P1-025-A]Comparison of Virulence and Pathogenicity between the NADC30-like Lineage 1 and the Lineage 3 Taiwan Betaarterivirus suid II in Pigs

*Yi-Fang Lai1, Chao-Nan Lin3, Ming-Tang Chiou3, Yen-Chen Chang1,2, Hui-Wen Chang1,2 (1. School of Veterinary Medicine, National Taiwan University (Taiwan), 2. Graduate Institute of Molecular and Comparative Pathology, School of Veterinary Medicine, National Taiwan University (Taiwan), 3. Department of Veterinary Medicine, National Pingtung University of Science and Technology (Taiwan))

[P1-028-A]A NEXT-GENERATION PRRSV2 MLV VACCINE IN A CONTROLLED COMPARATIVE FIELD TRIAL IN AN INDUSTRIAL SWINE SYSTEM IN CAMBODIA

Xuan Van Doan1, *Kriangsak Laosakul2, Philip Chhran2, Sarim Seng2, Sovanna Kem2 (1. Ceva Vietnam (Viet Nam), 2. CPF Cambodia (Cambodia))

[P1-031-A]IN VITRO AND IN VIVO ANTIVIRAL EFFECT OF CLEVIR-X AGAINST PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS

*Chanhee Chae1, Sehyeong Ham1, Jeongmin Suh1, Hyejin Na1 (1. College of Veterinary Medicine, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea (Korea))

[P1-034-A]EVALUATION OF IMMORTALIZED PORCINE MACROPHAGE CELL LINES FOR IMPROVED PROPAGATION OF PRRSV-1 AND PRRSV-2 ISOLATES

*Ayako MIYAZAKI1, Natsumi KISHIDA1, Michihiro TAKAGI1, Yuto SUDA1, Seiichi OHASHI1, Yoshihiro MUNETA1, Kasumi SUZUKI2, Gou YOSHIOKA2, Haruki KITAZAWA3, Hirohide UENISHI4, Takato TAKENOUCHI4 (1. National Institute of Animal Health, NARO (Japan), 2. Gifu Prefectural Livestock Research Institute (Japan), 3. Tohoku University (Japan), 4. Institute of Agrobiological Sciences, NARO (Japan))

[P1-037-A]Developing Broadly Neutralizing Lipid Nanoparticle mRNA Vaccines Against Swine Influenza H1N1

*Sophia Scobell1, Yi-Fang Lai2, Hui-Wen Chang1,2 (1. Graduate Institute of Molecular and Comparative Pathobiology, School of Veterinary Medicine, National Taiwan University (Taiwan), 2. School of Veterinary Medicine, National Taiwan University (Taiwan))

[P1-040-A]Spillover of contemporary human-origin Influenza A Virus in the Americas

*Michael A Zeller1, Daniel Carnevale de Almeida Moraes1, Giovana Ciacci Zanella3, Carine Souza2, Tavis K Anderson2, Amy L Baker2, Phillip C Gauger1 (1. Department of Veterinary Diagnostic & Production Animal Medicine, Iowa State University (United States of America), 2. Virus and Prion Research Unit, National Animal Disease Center, USDA-ARS (United States of America), 3. Department of Veterinary Microbiology & Preventive Medicine, Iowa State University (United States of America))

[P1-043-A]Comparative filed trial on the effectiveness of two commercial Mycoplasma hyopneumoniae &PCV2 vaccines in a PRRSV and PRV free farm

*Jun Zhang1,2, Roman Krejci3, Philippe Mazerolles3, Dean Wang1, Cathy Liu1, Hongguang Li1 (1. Ceva Animal Health (China), 2. College of Veterinary Medicine, Nanjing Agricultural University (China), 3. Ceva Animal Health France (France))

[P1-046-A]Induction of cellular immune response by porcine circovirus type 2a vaccine correlates with protection against a Korean circovirus type 2d challenge infection

*Yusik Oh1, Chaewun Bae1, Gijong Kang1, Jungjoon Cho2, Jeyeop Lee3, Sungseok Lee4 (1. Boehringer Ingelheim Animal Health Korea (Korea), 2. Sojung Animal Hospital (Korea), 3. Eden Animal Clinic (Korea), 4. Hue SMC Clinic (Korea))

[P1-049-A]Field Efficacy of efficacy of a new combined vaccine of porcine circovirus types 2a/d, Mycoplasma hyopneumoniae and M. hyorhinis

*Jeongmin Suh1, Sehyeong Ham1, Chanhee Chae1, Insong Kim, Kanghyeon Jeong2, Jihyun Jeong2, Bumsoo Park2, Youngkook You3 (1. Department of Veterinary Pathology, Colloge of Veterinary Medicine, Seoul National University (Korea), 2. R&D Center, Careside (Korea), 3. Careside Co., LTD. (Korea))

[P1-052-A]Comparative field efficacy study between non-vaccination and freshly mixed PCV2 and M. hyo vaccination

*Nontaprecha Bundee1, Termsitthi Paphavasit1, Kanokwan Samatiwat1, Piyachart Jitprodprong1, Nathaya Young1, Carmen Alonso2 (1. Boehringer Ingelheim Animal Health (Thailand) (Thailand), 2. Boehringer Ingelheim Vetmedica GmbH (Germany))

[P1-058-A]Efficacy of a PCV2d and Mycoplasma hyopneumoniae combined vaccine in piglets experimentally challenged with PCV2b

*Mònica Sagrera Cozar1,2,3, Laura Garza-Moreno3, Àlex Cobos1,2,4, Anna Maria Llorens1, Eva Huerta1, Mónica Pérez1, Diego Pérez1, David Espigares3, Joaquim Segalés2,4,5, Marina Sibila1,2,4 (1. IRTA, Animal Health, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra (Spain), 2. Unitat mixta d’investigació IRTA-UAB en Sanitat Animal, Centre de Recerca en Sanitat Animal (CReSA), Campus de la Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra (Spain), 3. Ceva Santé Animale (Spain), 4. WOAH Collaborating Center for Research and Control of Emerging and Re-emerging Pig Diseases (IRTA-CReSA), 08193 Bellaterra (Spain), 5. Departament de Sanitat i Anatomia Animals, Facultat de Veterinària, UAB, 08193 Bellaterra (Spain))

[P1-061-A]Compared field trial of different Mhyo-PCV2 vaccination protocols on consecutive batches in a farm with high infection pressure of PCV2d

Ainhoa Puig1, Albert Colomé1, Dolors Giralt1, Jordi Montané1, *Ignacio Bernal1, Ramon Jordà1, Ricard March1, Isaac Ballarà1 (1. HIPRA, Amer (Girona) (Spain))

[P1-064-A]A new PCV2 and Mycoplasma hyopneumoniae vaccine administered with needle-syringe or needle-free device demonstrates uncompromised efficacy against PCV2-d challenge

*István Kiss1, Nimród Pálmai1, Tamás Révész1, Han Smits2, Gwenaelle Dauphin2, Roman Krejci2, Philippe Mazerolles2 (1. Ceva Phylaxia, Budapest (Hungary), 2. Ceva Santé Animale, Libourne (France))

[P1-067-A]Efficacy of a PCV2d vaccine in Mexican field conditions

Aileen Nava2, Patzimba Alcantar2, Eric Bousquet1, Francisco Calvente1, *Leonardo Watte Watte1, Jorge Rodriguez3, Jesus Hernandez4 (1. Virbac SA (France), 2. Virbac (Mexico), 3. Consultant (Mexico), 4. CIAD (Mexico))

[P1-070-A]Risk factor analysis of postweaning multisystemic wasting syndrome (PMWS) in swine farms in Taiwan

Cheng-Ju Pan1,2, Yu-Liang Huang1, Jen-Chieh Chang1, Ming-Chung Deng1, *Wen-Yuan Yang2 (1. Veterinary Research Institute, Ministry of Agriculture, Executive Yuan (Taiwan), 2. Department of Veterinary Medicine, National Taiwan University (Taiwan))

[P1-076-A]A RETROSPECTIVE STUDY of PORCINE CIRCOVIRUS TYPE 4 in NURSERY PIG SERA in TAIWAN

Po-Chen Liu1, Wei-Cheng Lee1,2, Ming-Tang Chiou3,4, Chao-Nan Lin3,4, Wei-Hao Lin3,4, *Cheng-Yao Yang1,2 (1. Graduate Institute of Veterinary Pathobiology, National Chung Hsing University (Taiwan), 2. Animal Disease Diagnostic Center, National Chung Hsing University (Taiwan), 3. Department of Veterinary Medicine, National Pingtung University of Science and Technology (Taiwan), 4. Sustainable Swine Research Center, National Pingtung University of Science and Technology (Taiwan))

[P1-079-A]Preparation of a monoclonal antibody against porcine circovirus type 3 and development of an antibody sandwich enzyme-linked immunosorbent assay

*Zhen Li1,2, Jiaying Zhao1,2, Ang Tian1,2, Huanchun Chen1,2,3, Yunfeng Song1,2,3 (1. State Key Laboratory of Agricultural Microbiology, Huazhong Agricultural University, Wuhan, Hubei, 430070, China (China), 2. College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, 430070, China (China), 3. Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture and Rural Affairs of China, Wuhan, 430070, China (China))

[P1-082-A]Development of a Novel Porcine Epidemic Diarrhea Virus trVLP Vaccine

*Jintao Zhang1,2,3,4, Zhe Jiao1,2,3,4, Guiqing Peng1,2,3,4 (1. College of Animal Science and Technology, College of Veterinary Medicine, Huazhong Agricultural University (China), 2. National Key Laboratory of Exploration and Utilization of Agricultural Microbial Resources, Huazhong Agricultural University (China), 3. Collaborative Innovation Center for Healthy Swine Breeding (China), 4. Hubei Hongshan Laboratory (China))

[P1-085-A]Evaluation of Protective Efficacy of a G2b Live PEDV Vaccine via Intramuscular Injection Versus Oral Administration

*Min A Jeong1,3, Byoung Joo Seo1, Wooju Kwon1, Somin Lee1, Gyeong-Seo Park1, Bud Jung2, Minjoo Yeom3, Chong-Han Kim1, Daesub Song3 (1. Vaccine lab, WOOGENE B&G, South Korea (Korea), 2. Department of Pharmacy, College of Pharmacy, Korea University, Sejong-ro, Jochiwon-eup, Sejong-si, 30019, Republic of Korea (Korea), 3. Department of Virology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, Republic of Korea (Korea))

[P1-088-A]COST-EFFECTIVE PRODUCTION OF PORCINE PARVOVIRUS 1 VACCINE USING SILKWORM-BACULOVIRUS EXPRESSION SYSTEM

*Keiichi Esaki1,2, Tetsuo Sato3, Shizuka Hayashi3, Masahiro Taniguchi2, Hirokazu Nakatake2, Akitsu Masuda1, Jae Man Lee1, Nobuyuki Tsutsumi3, Yo Nakahara2, Kenta Yamato2, Takahiro Kusakabe1 (1. Graduate School of Bioresource and Bioenvironmental Sciences, Kyushu University (Japan), 2. KAICO ltd. (Japan), 3. Nippon Institute for Biological Science (Japan))

[P1-091-A]COMPARATIVE EVALUATION OF COMMERCIAL PORCINE PARVOVIRUS VACCINES ON REPRODUCTIVE PERFORMANCE ON A KOREAN SWINE FARM

*JeongJae Byun1, Hyundong Noh1, Sungwoon Choi1, Sanghyun Noh1, Joaquin M. Escuder2, JungHee Kim3 (1. HIPRA KOREA (Korea), 2. Hipra HQ. (Spain), 3. UNI A.H. (Korea))

[P1-094-A]Seroprevalence of Pseudorabies Virus Infections in Swine populations in Taiwan, 2023-2024

*Ching-Ping Tsai1, Shih-Ping Chen1 (1. Agricultural Technology Research Institute (Taiwan))